Foreclosures | Mortgages | Financing
Caliber Home Loans closed their 10,000th VA purchase loan in early August. Loan Consultant Lisa Kelly, in Caliber’s Sevierville, Tennessee, branch had the honors of originating the milestone loan for the company. …read more
From:: Real Estate Wire
Caliber Home Loans closed their 10,000th VA purchase loan in early August. Loan Consultant Lisa Kelly, in Caliber’s Sevierville, Tennessee, branch had the honors of originating the milestone loan for the company. …read more
From:: Real Estate Wire
“Getting a loan shouldn’t detract from the excitement of buying a home — it should celebrate the unbridled joy of becoming a homeowner,” said Uday Devalla, CIO of Stearns Lending. “orijin was developed to provide this end-to-end digital experience that is simple, not rocket science.” …read more
From:: Real Estate Wire
With Tavant’s FinXperience Suite, lenders have the ability to not only keep all their customers and partners engaged in an immersive experience with real time statuses and process updates, but most importantly, to provide them with the ability to drive the lending transaction in a seamless manner. …read more
From:: Real Estate Wire
By swheeler@housingwire.com New consumer expectations for a faster, easier mortgage process have turned up the heat on financial institutions to deliver a better customer experience for borrowers. Speed and accuracy are more important than ever as potential buyers compete for limited inventory, and financial institutions compete for those borrowers. Fortunately, these 16 companies stand ready to help, offering solutions that span the entire mortgage loan lifecycle. …read more
From:: Real Estate Wire
Past due payments on securitized commercial real estate loans turned lower as the wall of maturities subsided. The improvement was led by industrial loans.
The rate of 30-day delinquency on loans that are contained in commercial mortgage-backed securities wound up at 3.04 percent as of the end of July.
That was a 15-basis-point improvement over the previous month. Compared to the same month last year, CMBS delinquency has fallen 8 BPS.
From:: Financing
Again, serious delinquency at the Federal National Mortgage Association has fallen to the lowest level in the past decade. New business maintained.
The Washington-based secondary lender’s book of business ended July at $3.1782 trillion, according to its monthly summary.
Growth was recorded versus a month earlier, when the balance was $3.1754 trillion, and a year earlier, when it stood at $3.1032 trillion.
From:: Financing
“As part of our comprehensive strategy to deliver the first true digital mortgage to the industry, we are helping lenders to originate more loans, reduce costs, and complete the entire mortgage process faster,” said Jonathan Corr, president and CEO of Ellie Mae. “The combination of Velocify’s solution with our Encompass CRM and Encompass Consumer Connect solutions will accelerate our delivery of the most robust digital mortgage solution in the market.” …read more
From:: Real Estate Wire
Senior executives of the Federal Home Loan Bank of Dallas have been indicted for using funds from the organization to pay for personal expenses.
An announcement Thursday from the Department of Justice indicated that Terence C. Smith, Michael J. Sims and Nancy B. Parker have all been indicted.
Smith, 51, was the president and chief executive officer of FHLB Dallas from 2000 through September 2013, while Sims, 51, was the chief financial officer from 2005 through May 2014.
From:: Financing
Shares of Aptevo Therapeutics Inc. more than doubled late Thursday after the tiny Seattle-based biotech company said it ended a partnership with German biotech company MorphoSys AG for a prostate cancer drug candidate and plans to develop the drug on its own. Aptevo shares soared 134% to $3.11 after hours. Aptevo said it ended a commercialization and development partnership with MorphoSys and plans to advance the drug APVO414 through early-stage clinical trials for the treatment of metastatic castration resistant prostate cancer. Separately, Aptevo said it’s agreed to sell three of its marketed products to Saol Therapeutics for $65 million, plus milestone payments and accounts receivable payments of up to $9.5 million. Those products are WinRho SDF for autoimmune platelet disorder, Hepatitis B drug HepaGam B and varicella zoster virus treatment Varizig.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News